Combination of Basiliximab and Pegaspargase in the Treatment of ENKTCL

Condition:   Extranodal NK/T-cell Lymphoma Interventions:   Drug: Basiliximab;   Drug: Pegaspargase Sponsor:   Beijing Tongren Hospital Not yet recruiting

Source: ClinicalTrials.gov - April 7, 2020 Category: Research Source Type: clinical trials